The Evolution and Treatment of Korsakoff's Syndrome
详细信息 查看全文
- 作者：A. D. Thomson (12)
Irene Guerrini (3)
E. Jane Marshall (24) jane.marshall@slam.nhs.uk - 关键词：Thiamine deficiency – ; Wernicke’ ; s encephalopathy – ; Korsakoff’ ; s Syndrome – ; Alcohol neurotoxicity
- 刊名：Neuropsychology Review
- 出版年：2012
- 出版时间：June 2012
- 年：2012
- 卷：22
- 期：2
- 页码：81-92
- 全文大小：233.1 KB
- 参考文献：1. Acker, W., Aps, E. J., Majumdar, S. K., Shaw, G. K., & Thomson, A. D. (1982). The relationship between brain and liver damage in chronic alcoholic patients. Journal of Neurology, Neurosurgery and Psychiatry, 45, 984–987.
2. Ambrose, M. L., Bowden, S. C., & Whelan, G. (2001). Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol: Clinical and Experimental Research, 25, 112–116.
3. Baker, H., Thomson, A. D., & Frank, O. (1974). Absorption and passage of fat and water soluble thiamine derivatives into erythrocytes and cerebro-spinal fluid in man. American Journal of Clinical Nutrition, 27, 676–680.
4. Brust, J. C. M. (2010). Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. International Journal of Environmental Research Public Health, 7, 1540–1557.
5. Butterworth, R. F., Kril, J. J., & Harper, C. (1993). Thiamine-dependent enzyme changes in brain of alcoholics: relationship to Wernicke–Korsakoff syndrome. Alcoholism, Clinical and Experimental Research, 17, 1084–8.
6. Caine, D., Halliday, G. M., Krill, J. J., & Harper, C. G. (1997). Operational criteria for the classification of chronic alcoholics: identification of Wernicke’s Encephalopathy. Journal of Neurology, Neurosurgery & Psychiatry, 62, 51–60.
7. Charness, M. E. (2006). Alcohol. In J. Noseworthy (Ed.), Neurological therapeutics (pp. 1677–1685). London: Martin Dunitz.
8. Ciccia, R. M., & Langlais, P. J. (2000). An examination of the synergistic interaction of ethanol and thiamine deficiency in the development of neurological signs and long term cognitive and memory impairments. Alcoholism, Clinical and Experimental Research, 24, 622–634.
9. Cook, C. C., Hallwood, P. M., & Thomson, A. D. (1998). B-vitamin deficiency and neuro-psychiatric syndromes in alcohol misuse. Alcohol and Alcoholism, 33, 317–316.
10. Crowe, S. F., & Kempton, S. (1997). Both ethanol toxicity and thiamine deficiency are necessary to produce long-term memory deficits in the young chick. Pharmacology, Biochemistry and Behaviour, 58, 461–70.
11. Crowe, S. F., & El-Hadj, D. (2002). Phenytoin ameliorates the memory defect induced in the young chick by ethanol toxicity in association with thiamine deficiency. Pharmacology, Biochemistry and Behaviour, 71, 215–221.
12. Day, E., Bentham, P., Callaghan, R., et al. (2008). Thiamine for Wernicke–Korsakoff Syndrome in people at risk from alcohol abuse (review). The Cochrane Collaboration. Chichester: Wiley.
13. De Wardener, H. E., & Lennox, B. (1947). Cerebral beriberi (Wernicke's Encephalopathy): review of 52 cases in a Singapore prisoner-of-war hospital. Lancet, 1, 11–17.
14. Diaz, G. A., Banikazemi, M., Oishi, K., Desnick, R. J., & Gelb, B. D. (1999). Mutations in a new gene encoding a thiamine transporter cause thiamine- responsive megaloblastic anaemia syndrome. Nature Genet, 22, 309–12.
15. Flink, E. B. (1969). Therapy of magnesium deficiency. Ann NY Academy of Science, 162, 901–905.
16. Galvin, R., Br氓then, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010). EFNS guidelines for diagnosis, therapy and prevention of Wernicke Encephalopathy. European Journal of Neurology, 17, 1408–1418.
17. Gilchrist, G., & Morrison, D. (2005). Prevalence of alcohol-related brain damage among homeless hostel dwellers in Glasgow. European Journal of Public Health, 15, 587–588.
18. Greenwood, J., & Pratt, O. E. (1982). Inhibition of thiamine transport across the blood–brain barrier in the rat by chemical analogue of the vitamin. The Journal of Physiology, 336, 479–486.
19. Greenwood, J., Love, E. R., & Pratt, O. E. (1980). Carrier mediated transport of thiamine across the blood–brain barrier. Proceedings of the Physiological Society, Journal of Physiology, 310, 23.
20. Guerrini, I., Thomson, A. D., Cook, C. C. H., et al. (2004). Direct genomic sequencing of the high affinity thiamine transporter gene and the OGDH gene in alcoholics with Wernicke-Korsakoff Syndrome. Am J Med Genetics (Neuropsychiatric Genetics), 130B, 17–18.
21. Guerrini, I., Thomson, A. D., Cook, C. C., McQuillin, A., Sharma, V., Kopelman, M., Reynolds, G., Jauhar, P., Harper, C., & Gurling, H. M. (2005). Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19A2) gene identifies three genetic variants in Wernicke Korsakoff syndrome (WKS). AmJ Med Genet B Neuropsychiatr Genet, 137, 17–19.
22. Guerrini, I., Thomson, A. D., & Gurling, H. M. (2009). Molecular genetics of alcohol related brain damage. Alcohol and Alcoholism, 44, 166–170.
23. Harper, C. (2006). Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe. European Journal of Neurology, 13, 1–6.
24. Harper, C. G., Sheedy, D. L., Lara, A. I., et al. (1988). Prevalence of Wernicke–Korsakoff syndrome in Australia: Has thiamine fortification made a difference? The Medical Journal of Australia, 168, 542–5.
25. Harper, C., Dixon, G., Sheedy, D., et al. (2003). Neuropathological alterations in alcoholic brains. Studies arising from the New South Wales Tissue Resource Centre. Prog Neuropsychopharmacol Biol Psychiatry, 27, 951–61.
26. Heap, L. C., Pratt, O. E., Ward, R. J., et al. (2002). Individual susceptibility to Wernicke–Korsakoff syndrome and alcoholism induced cognitive deficit: impaired thiamine utilization found in alcoholics and alcohol abusers. Psychiatric Genetics, 12, 217–224.
27. Hoyumpa, A. M., Nichols, S., Schenker, S., & Wilson, F. N. (1976). Thiamine transport in thiamine-deficient rats. Biochem Biophys Acta, 436, 438.
28. Howard, L. C., Wagner, C., & Schenker, S. (1974). Malabsorption of thiamine in folate deficient rats. Journal of Nutrition, 104, 1024.
29. Jacobson, R. R., & Lishman, W. A. (1987). Selective memory loss and global intellectual deficits in alcoholic Korsakoff’s syndrome. Psychological Medicine, 17, 649–655.
30. Keedwell, P. A., Poon, L., Papadopoulos, A. S., Marshall, E. J., & Checkley, S. (2001). Salivary cortisol during a medically assisted alcohol withdrawal. Addiction Biology, 6, 247–257.
31. Kono, S., Miyajima, H., Yoshida, K., Togawa, A., Shirakawa, K., & Suzuki, H. (2009). Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. The New England Journal of Medicine, 360, 1792–4.
32. Kopelman, M. (1989). Remote and autobiographical memory, temporal context memory and frontal atrophy in Korsakoff and Alzheimer patienta. Neuropsychologica, 27, 437–460.
33. Kopelman, M. D., Thomson, A. D., Guerrini, I., & Marshall, E. J. (2009). The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol and Alcoholism, 44, 148–154.
34. Leenane, K. J. (1986). Management of moderate to severe alcohol-related brain damage (Korsakoff’s Syndrome). Medical Journal of Australia, 145, 136–143.
35. Leevy, C. M., Cardi, L., Frank, O., Gellene, R., & Baker, H. (1965). Incidence and significance of hypovitaminemia in a randomly selected municipal hospital population. American Journal of Clinical Nutrition, 17, 259–271.
36. Lieber, C. S., & De Carli, L. M. (1989). Liquid diet technique of ethanol administration: 1989 update. Alcohol and Alcoholism, 24, 197–211.
37. Lindberg, M. C., & Oyler, R. A. (1990). Wernicke’s Encephalopathy. American Family Physician, 41, 1205–1209.
38. Lingford-Hughes, A. R., Welch, S., & Nutt, D. J. (2004). Evidence based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacology, 18, 293–335.
39. Lishman, W. A. (1990). Alcohol and the brain. The British Journal of Psychiatry, 156, 635–644.
40. Littlewood NK, McWhirter K, Mcnaughton G (2008) Pabrinex庐 prescribing in Scottish emergency departments. Poster presented at the Inaugural Scientific Conference of The College of Emergency Medicine, London, UK; 14–16 May 2008
41. MacRae, S., & Cox, S. (2003). Meeting the needs of people with alcohol related brain damage: a literature review on the existing and recommended service provision and models of care. Sterling: University of Sterling.
42. McIlwain, H., & Bachelard, H. (1971). Biochemistry and the nervous system, 4th edn (pp 226–307). Edinburgh: Churchill Livingstone.
43. Mancinelli, R., Ceccani, M., Guiducci, M. S., et al. (2003). Simultaneous liquid chromatography assessment of thiamine, thiamine monophosphate and thiamine diphosphate in human erythrocytes: a study on alcoholics. Journal of Chromatography, 789, 355–363.
44. Marshall, E. J., Humphreys, K., & Ball, D. M. (2010). The treatment of drinking problems (5th ed.). Cambridge: Cambridge University Press.
45. Matsumoto, I. (2009). Proteomics approach in the study of the pathophysiology of alcohol-related brain damage. Alcohol and Alcoholism, 44, 171–176.
46. Mendelson, J. H., & Stein, S. (1966). Serum cortisol levels in alcoholic and non-alcoholic subjects during experimentally induced ethanol intoxication. Psychosomatic Medicine, 28, 212–226.
47. Nakada, T., & Knight, R. T. (1984). Alcohol and the central nervous system. The Medical Clinics of North America, 68, 121–131.
48. NICE (2011). Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. Clinical Guideline 115. London: NICE.
49. Nishino, K., & Itokawa, Y. (1977). Thiamine metabolism in vitamin B6 and B12 deficient rats. Nutrition, 107, 775.
50. Pitel, A.-L., Beaunieux, H., Witkowski, T., Vabret, F., de la Sayette, V., Viader, F., Desgranges, B., & Eustache, F. (2008). Episodic and working memory deficits in alcoholic Korsakoff patients: the continuity theory revisited. Alcohol: Clinical and Experimental Research, 32, 1229–1241.
51. Pitel, A.-L., Zahr, N. M., Jackson, K., Sassoon, S. A., Rosenbloom, M. J., Pfefferbaum, A., & Sullivan, E. V. (2011). Signs of preclinical Wernicke’s encephalopathy and thiamine levels as predictors of neuropsychological deficits in alcoholism without Korsakoff’s Syndrome. Neuropsychopharmacology, 36, 580–588.
52. Pratt, O. E., Jeyasingham, M., Shaw, G. K., et al. (1985). Transketolase variant enzymes and brain damage. Alcohol and Alcoholism, 20, 223–232.
53. Price, J., Mitchell, S., Wiltshire, B., Graham, J., & Williams, G. (1988). A follow-up study of patients with alcohol-related brain damage in the community. Australian Drug and Alcohol Review, 7, 83–87.
54. Price, J., Hicks, M., & Williams, G. (1993). A feature of alcoholic Wernicke’s encephalopathy favourable to the maintenance of memory function: vomiting. Alcohol and Alcoholism, 28, 339–345.
55. Ramayya, A., & Jauhar, P. (1997). Increasing incidence of Korsakoff’s psychosis in the East End of Glasgow. Alcohol and Alcoholism, 32, 281–285.
56. Rindi, G., Patrini, C., Comincioli, V., & Reggiani, C. (1980). Thiamine content and turnover rates of some rat nervous regions, using labeled thiamine as a tracer. Brain Research, 81, 369–80.
57. Royal College of Physicians. (2001). Alcohol-can the NHS afford it? Recommendations for a coherent alcohol strategy for hospitals. London: Royal College of Physicians.
58. Russell, C., & Elia, M. (2009). Nutrition screening survey in the UK in 2008: hospitals, care homes and mental health units. Redditch: British Association for Parenteral and Enteral Nutrition.
59. Sechi, G., & Serra, A. (2007). Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurology, 6, 442–455.
60. Subramanian, V. S., Subramanya, S. B., Tsukamoto, H., & Said, H. M. (2010). Effect of chronic alcohol feeding of physiological and molecular parameters of renal thiamine transport. American Journal of Physiology – Renal Physiology, 299(1), F28–F34.
61. Subramanya, S. B., Subramanian, V. S., & Said, H. M. (2010). Chronic alcohol consumption and intestinal thiamin absorption: effects on physiological and molecular parameters of the uptake process. American Journal of Physiology – Gastrointestinal and Liver Physiology, 299(1), G23–G31.
62. Thomson, A. D. (1966). The absorption of sulphur-labelled thiamine hydrochloride in control subjects and in patients with intestinal malabsorption. Clinical Science, 31(2), 167–179.
63. Thomson, A. D. (2000). Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff Syndrome. Alcohol and Alcoholism, 35(Suppl. 1), 2–7.
64. Thomson, A. D., & Leevy, C. M. (1972). Observations on the mechanism of thiamine hydrochloride absorption in man. Clinical Science, 43, 153.
65. Thomson, A. D., & Marshall, E. J. (2006). The treatment of patients at risk of developing Wernicke's encephalopathy in the community. Alcohol and Alcoholism, 41, 159–167.
66. Thomson, A. D., Baker, H., & Leevy, C. M. (1968). Thiamine absorption in alcoholism. American Journal of Clinical Nutrition, 21, 537.
67. Thomson, A. D., Baker, H., & Leevy, C. M. (1970). Patterns of 35S-thiamine hydrochloride absorption in the malnourished alcoholic. Journal of Laboratory and Clinical Medicine, 76(1), 34–45.
68. Thomson, A. D., Frank, O., Baker, H., et al. (1971). Thiamine propyl disulfide: absorption and utilization. Annals of Internal Medicine, 74, 529–534.
69. Thomson, A. D., Frank, O., De Angelis, B., & Baker, H. (1972). Thiamine depletion induced by dietary folate deficiency in rats. Nutrition Reports International, 6, 107–110.
70. Thomson, A. D., Ryle, P. R., & Shaw, G. K. (1983). Ethanol, thiamine and brain damage. Alcohol and Alcoholism, 18, 27–43.
71. Thomson, A. D., Jeyasingham, M., Pratt, O. E., et al. (1987). Nutrition and alcoholic encephalopathies. Acta Medica Scandinavica. Supplementum, 717, 55–65.
72. Thomson, A. D., Cook, C. C. H., Touquet, R., et al. (2002). The Royal College of Physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy in the Accident and Emergency Department. Alcohol and Alcoholism, 37, 513–521.
73. Thomson, A. D., Cook, C. C. H., Guerrini, I., et al. (2008). Wernicke’s Encephalopathy: plus ca change, plus c’est la meme chose. Alcohol and Alcoholism, 43, 180–186.
74. Thomson, A. D., Guerrini, I., & Marshall, J. E. (2009). Wernicke’s encephalopathy: role of thiamine. Practical Gastroenterol, XXXIII(6), 21–30.
75. Thomson, A. D., Guerrini, I., Bell, D., Drummond, C., Duka, T., Field, M., Kopelman, M., Lingford-Hughes, A., Smith, I., Wilson, K., & Marshall, E. J. (2012). Alcohol related brain damage: report from a medical council on alcohol symposium, June 2010. Alcohol Alcoholism, 47(2), 84–91.
76. Torvik, A., Lindboe, C. F., & Rogde, S. (1982). Brain lesions in alcoholics. A neuopathological study with clinical correlations. Journal of Neurological Sciences, 56, 233–248.
77. Victor, M., & Adams, R. D. (1985). The alcoholic dementias. In P. J. Vinken, G. W. Bruyn, & H. L. Klawans (Eds.), Handbook of clinical neurology (Vol 46, pp. 335–353). Amsterdam: Elsevier.
78. Victor, M., Adams, R. D., & Collins, G. H. (1971). The Wernicke–Korsakoff Syndrome. Philadelphia, PA: F.A. Davis.
79. Victor, M., Adams, R. D., & Collins, G. H. (1989). The Wernicke–Korsakoff Syndrome and related neurological disorders due to alcoholism and malnutrition. Philadelphia, PA: F.A. Davis.
80. Witt, E. D., & Goldman-Rakic, P. S. (1983a). Intermittent thiamine deficiency in the rhesus monkey. 1. Progression of neurological signs and neuroanatomical lesions. Annals of Neurology, 13, 376–395.
81. Witt, E. D., & Goldman-Rakic, P. S. (1983b). Intermittent thiamine deficiency in the rhesus monkey. II Evidence for memory loss. Ann Neurol, 13, 396–401.
82. Wood, B. (1985). Thiamin status in Australia. World Review of Nutrition and Dietetics, 46, 148–218.
83. Wood, B., Currie, J., & Breen, K. (1986). Wernicke’s encephalopathy in a metropolitan hospital: a prospective study of the incidence, characteristics and outcome. Medical Journal of Australia, 144, 12–16.
84. Yamada, K., Miura, K., Hara, K., Suzuki, M., Nakanishi, K., Kumagai, T., Ishihara, N., Yamada, Y., Kuwano, R., Tsuji, S., & Wakamatsu, N. (2010). A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Medical Genetics, 11, 171.
85. Zahr, N., Kaufman, K. L., & Harper, C. G. (2011). Clinical and pathological features of alcohol-related brain damage. Nature Reviews Neurology, 7, 284–294.
86. Zeng, W. Q., Al-Yamani, E., Acierno, J. S., Jr., Slaugenhaupt, S., Gillis, T., MacDonald, M. E., Ozand, P. T., & Gusella, J. F. (2005). Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. American Journal of Human Genetics, 77, 16–26. - 作者单位：1. Molecular Psychiatry Laboratory, Rockefeller Building, University College London, 21 University Street, London, UK2. Institute of Psychiatry, King鈥檚 College London, London, UK3. Bexley Substance Misuse Service, South London & Maudsley NHS Foundation Trust, London, UK4. South London & Maudsley NHS Foundation Trust, Maudsley Hospital, Denmark Hill, London, SE5 8AZ UK
- 刊物类别：Behavioral Science
- 刊物主题：Psychology
Neuropsychology
Neurology
Neuroradiology
Health Psychology - 出版者：Springer Netherlands
- ISSN：1573-6660
文摘
Wernicke’s Encephalopathy is an acute neuro-psychiatric condition caused by an insufficient supply of thiamine (Vitamin B1) to the brain. If undiagnosed or inadequately treated, it is likely to proceed to Korsakoff’s Syndrome. Wernicke’s Encephalopathy can result from dietary deficiency alone and this form is usually successfully treated, with little chance of Korsakoff’s Syndrome supervening. On the other hand, thiamine deficiency associated with alcohol misuse/dependence may require up to 1 gram of thiamine IV in the first 24 hours to be treated successfully. The reasons for this difference in treatment will be discussed. Thiamine diphosphate acts as a co-factor for a number of thiamine-dependent enzymes. Thiamine deficiency leads to a reduction in the activity of these enzymes, and this leads to alterations in mitochondrial activity, impairment of oxidative metabolism, decreased energy status and eventually selective neuronal death. The damage caused by the combination of thiamine deficiency and alcohol metabolism probably interferes with adequate thiamine transport at a number of sites in the body, including the blood–brain barrier, as well as causing damage to the apoenzymes which then require higher concentrations of thiamine to work normally. The accumulated damage is likely to render the use of oral thiamine therapeutically inadequate since the body is unable to produce high enough concentrations of thiamine in the blood to traverse the blood–brain barrier. Some individuals are probably genetically predisposed to develop Wernicke’s. Long before individuals with alcohol misuse or dependence develop Wernicke’s Encephalopathy the neurons and other cells of the body are functioning sub-optimally because of the inadequate supply of thiamine and the neurotoxic effect of alcohol. This relative deficiency initiates a series of pathological changes which accumulate and further interfere with the supply of thiamine and its utilisation at a time when the requirements are increased. The best treatment for Korsakoff’s Syndrome is timely recognition of Wernicke’s Encephalopathy and appropriate intervention and prevention.